Face Bones Involvement and Relapse in a Case of Childhood Acute Leukemia
Journal Title: Iranian Journal of Blood and Cancer - Year 2015, Vol 7, Issue 2
Abstract
Midface bones are an unusual site for primary presentation and relapse in acute lymphoblastic leukemia. Herein, we describe a case of acute pre B cell lymphoblastic leukemia with leukemic infiltration of maxilla and bone marrow involvement. At the time of relapse, the patient presented again with maxilla involvement and the phenotype changed to biphenotypic lymphoblastic leukemia. Our case suggests that leukemic involvement of the maxilla should be considered in differential diagnosis of patients presenting with acute painful midface swelling. These patients should be evaluated using imaging modalities, blood parameters and histopathology. Keywords: Face, bone, leukemia, relapse, acute lymphoblastic leukemia.
Authors and Affiliations
B Abdolkarimi, S Zareifar, M Mokhtari
Editorial note
This article has no abstract
Seroprevalence of Transfusion-transmitted Infections Among Multi-transfused Patients in Southwest Iran, Khuzestan Province
Background: Transfusion-transmited infections (TTIs) continue to be a problem in many parts of the world and multi-transfused patients are at a particularly increased risk for TTIs. The aim of this study was to determine...
Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran
Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. Dexrazoxane is co-administrated with doxorubicin to prevent its cardiotoxicity. Here we have explored some alternative food or drugs to be us...
Clinicopathological Features of Non-metastatic Triple Negative Breast Cancer
Background: Triple negative breast cancer (TNBC) is reported to be associated with a high risk of recurrence, poor overall survival (OS), and disease-free survival (DFS) rates. This study evaluated the clincopathological...
Treatment of a Child with Refractory Acute Myeloid Leukemia with Humanized Anti-CD33 Monoclonal Antibody: A Case Report and Review of Drug Development
Background: The induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. For patients w...